The QUT Institute of Health and Biomedical Innovation in Australia is building a dedicated facility. Although you still are unable to get 3D-printed liver transplant made from your own cells. An Australian hospital is trying to progress the technology into the mainstream. The Queensland University of Technology (QUT) is Brisbane is building a dedicated “bio-fabrication” space in which physicians and researchers can produce technology to model and print cartilage, bone and other human tissue. It will be the first time a biomanufacturing Institute will be co-located with a high-level hospital in Australia.
With the goal of having 3D printing assisting surgeons in the operating the room. This 3D printing will covers areas of the body they are to operate on; and printing a “scaffold” that can be embedded as a replacement.
The facility will utilize two floors of the hospital use state of the art tissue manufacturing technology in surgery procedures. According to the Australian Minster of Health Cameron Dick, The vision is for healthcare is that the fabrication Institute will pave the way for 3D printers to sit in operating theaters, ready to print tissue as needed, in our hospital of the future.
Since 3D printing for 3D tissue and medical implanting is still in the early days, QUT is pushing the limits fo what is currently available along with WakeForest University in North Carolina and Harvard University in Cambridge, Massachusetts. Along with other. Researchers have started to grow ( although not 3D printed ) bladders of practices’ own cells and effectively transplanted them and joined human ear prostheses made partially from living tissue. Building more complex organs (like highly sought kidneys) has proven a hurdle, in part because it’s difficult to supply blood to them and keep them alive for longer than a few months.
Biofabrication shows the most outlook for less complex body parts like cartilage and bone There cartilage and bone. There are many of implants into a patient and as the tissue grow back. Since it is not rejected, the scaffold is reabsorbed over time, and the tissue will grow even more and eventually the implant is gone. Manufacturers don’t always have to use metallic implants A more; we can develop extraordinarily high-spec composite material that dissolves the tissue heals.